A Window of Opportunity Study to Characterize the Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics of CPX-POM in Patients with Newly Diagnosed or Recurrent Bladder Tumors
A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG?Na�ve High?Grade Non?Muscle Invasive Bladder Cancer.
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab
MSB0010718C in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in
Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not
Progress with First Line Platinum-Containing Chemotherapy